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Abstract
Tripartite motif protein 22 (TRIM22) is an evolutionarily ancient protein that plays an integral role in the host innate immune
response to viruses. The antiviral TRIM22 protein has been shown to inhibit the replication of a number of viruses, including
HIV-1, hepatitis B, and influenza A. TRIM22 expression has also been associated with multiple sclerosis, cancer, and
autoimmune disease. In this study, multiple in silico computational methods were used to identify non-synonymous or
amino acid-changing SNPs (nsSNP) that are deleterious to TRIM22 structure and/or function. A sequence homology-based
approach was adopted for screening nsSNPs in TRIM22, including six different in silico prediction algorithms and
evolutionary conservation data from the ConSurf web server. In total, 14 high-risk nsSNPs were identified in TRIM22, most of
which are located in a protein interaction module called the B30.2 domain. Additionally, 9 of the top high-risk nsSNPs
altered the putative structure of TRIM22’s B30.2 domain, particularly in the surface-exposed v2 and v3 regions. These same
regions are critical for retroviral restriction by the closely-related TRIM5a protein. A number of putative structural and
functional residues, including several sites that undergo post-translational modification, were also identified in TRIM22. This
study is the first extensive in silico analysis of the highly polymorphic TRIM22 gene and will be a valuable resource for future
targeted mechanistic and population-based studies.
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Introduction
Single nucleotide polymorphisms (SNPs), defined as single base
changes in a DNA sequence, are responsible for the majority of
genetic variation in the human population. Although many SNPs
are phenotypically neutral, non-synonymous SNPs (nsSNPs) often
have deleterious effects on protein structure or function. NsSNPs
are located in protein coding regions and result in an amino acid
substitution in the corresponding protein product. As such,
nsSNPs can alter the structure, stability, or function of proteins,
and are often associated with human disease. Indeed, previous
studies have shown that approximately 50% of the mutations
involved in inherited genetic disorders are due to nsSNPs [1–3].
Recently, a number of genetic studies have focused on nsSNPs in
innate immune genes. These studies have identified multiple
nsSNPs that influence susceptibility to infection, as well as the
development of inflammatory disorders and autoimmune diseases
[4–9]. Nonetheless, because innate immune genes are often highly
polymorphic, many nsSNPs in these genes remain uncharacter-
ized.
Members of the tripartite motif (TRIM) protein family are
involved in a wide range of biological processes related to innate
immunity [10–12]. TRIM proteins are defined by an RBCC
motif, which consists of a RING domain, one or two B-box
domains, and a predicted coiled-coil region. Most TRIM proteins
also have a protein interaction module called a B30.2 domain at
their C-terminus [13–15]. Many TRIM proteins are induced by
interferon signaling and several possess antiviral activity, in
particular against the Retroviridae family of viruses. Recent studies
have implicated TRIM proteins in the regulation of pathogen-
recognition signaling pathways, a finding that has sparked
considerable interest in understanding how TRIM family proteins
contribute to the innate immune response [16–21].
One well-studied member of the TRIM family, TRIM5a, is
required for the species-specific block against HIV-1 replication in
primate cells [22–24]. Recently, TRIM5a was also shown to
promote innate immune signaling and to function as an innate
immune sensor for the retrovirus capsid lattice in vitro. Previous
studies have established that TRIM5a binds to the HIV-1 capsid
protein in the mature viral core via four variable regions (v1-v4) in
its B30.2 domain [25,26]. The v1 or ‘antiviral patch’ region was
previously shown to be the major determinant for species-specific
HIV-1 restriction by TRIM5a. Mutations in the other variable
regions (v2-v4) have also been shown to interfere with TRIM5a-
mediated restriction of HIV-1, SIV, and N-MLV [22,26–29].
Notably, analogous variable regions are found in several other
B30.2-containing TRIM proteins [30,31,32].
Human TRIM5 is located on chromosome 11 within a cluster of
four closely-related TRIM genes that also includes TRIM6,
TRIM22, and TRIM34. TRIM5 and TRIM22 have an ancient
and dynamic evolutionary relationship, whereby both genes have
evolved under positive selection for millions of years in a mutually
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exclusive manner [33]. Similar to TRIM5a, TRIM22 has also
been shown to inhibit HIV-1 replication in a number of human
cell lines and primary monocyte-derived macrophages [34–37].
TRIM22 expression levels have also been shown to influence
HIV-1 infection in vivo [37,38,39]. Interestingly, nsSNPs in
TRIM5a, including H43Y, R136Q, and G249D, significantly
alter HIV-1 acquisition and disease progression in humans [40–
43]. Despite TRIM22’s highly polymorphic nature, it is unknown
how nsSNPs affect its biological and/or antiviral functions. Here,
multiple in silico computational methods were used to identify
nsSNPs in the TRIM22 gene that are predicted to be highly
deleterious to TRIM22 structure and/or function. A total of 14
high-risk nsSNPs were identified, including 9 that altered the
putative structure of TRIM22’s B30.2 domain. A number of sites
predicted to undergo post-translational modification (ubiquityla-
tion, sumoylation, phosphorylation) were also identified. This
study is the first extensive in silico analysis of the TRIM22 gene and
will establish a strong foundation for future structure-function and
population-based studies.
Materials and Methods
Retrieval of SNPs
Polymorphism data for the TRIM22 gene were retrieved from
the following databases: the UniProt database (http://www.
uniprot.org) (UniProtKB ID Q8IYM9), the NCBI dbSNP
database (https://www.ncbi.nlm.nih.gov/SNP/), 1000 Genomes
(http://www.1000genomes.org/), and the Ensembl genome
browser (http://www.ensembl.org/index.html). Minor allele fre-
quencies were obtained from the NCBI dbSNP database, the
Ensembl genome browser, and the 1000 Genomes browser [44–
46].
Non-synonymous SNP analysis
Functional effects of nsSNPs were predicted using the following
in silico algorithms: Polyphen-2 (http://genetics.bwh.harvard.edu/
pp2), SIFT (http://sift.jcvi.org/), nsSNP Analyzer (http://
snpanalyzer.uthsc.edu/), PhD-SNP (http://snps.biofold.org/phd-
snp/phd-snp.html), SNPs&GO (http://snps-and-go.biocomp.
unibo.it/snps-and-go/), and PMut (mmb2.pcb.ub.es:8080/PMut)
[47–52]. nsSNPs predicted to be deleterious by at least four in silico
algorithms were categorized as high-risk nsSNPs and were selected
for further analysis.
Phylogenetic analysis
Evolutionary conservation of amino acid residues in TRIM22
was determined using the ConSurf web server (consurf.tau.ac.il/)
[53]. In ConSurf, 14 TRIM22 homologues were aligned and
position-specific conservation scores were calculated using an
empirical Bayesian algorithm (Conservation Scores: 1–4 Variable,
5–6 Intermediate, and 7–9 Conserved). Putative functional and
structural residues were also predicted using ConSurf by
combining evolutionary conservation scores with solvent accessi-
bility predictions (Figures S1 and S2). Highly conserved amino
acids that were located at high-risk nsSNP sites were selected for
further analysis.
Structural analysis
3D-Jigsaw was used to generate 3D structural models for wild
type TRIM22 (UniProtKB Q8IYM9) and each of the 9 high-risk
nsSNPs in TRIM22’s B30.2 domain. For each model, only the
B30.2 sequence was submitted. 3D-Jigsaw searches multiple
sequence databases (e.g. PFAM and PDB) and builds structures
based on homologues of known structure [54]. Models were
viewed using the Swiss-PdbViewer (http://www.expasy.org/
spdbv/) [55]. Tm-Align was used to calculate Tm-scores and root
mean square deviation (RMSD) (http://zhanglab.ccmb.med.
umich.edu/TM-align/) [56].
Prediction of post-translational modification sites
Putative ubiquitylation sites were predicted using the UbPred
(www.ubpred.org) and BDM-PUB (bdmpub.biocuckoo.org) pro-
grams [2]. In UbPred, lysine residues with a score of $0.62 were
considered ubiquitylated. For BDM-PUB, the balanced cut-off
option was selected. Putative sumoylation sites were predicted
using the SUMOplot (http://www.abgent.com/sumoplot) and
SUMOsp 2.0 (http://sumosp.biocuckoo.org/) programs [57]. For
SUMOplot, only high probability motifs with a score .0.5 were
considered sumoylated. Medium level threshold with a 2.64 cut-off
value was selected for SUMOsp 2.0 analysis. Putative phosphor-
ylation sites were predicted using GPS 2.1 (http://gps.biocuckoo.
org/) and NetPhos 2.0 (http://www.cbs.dtu.dk/services/
NetPhos/) [58,59]. For GPS 2.1 analysis, high level threshold
with cut-off values ranging from 0.776-11 were selected. In
NetPhos 2.0, serine, threonine, and tyrosine residues with a score
of .0.5 were considered phosphorylated. Sumo-interacting motifs
(SIM) were identified manually and compared to experimentally
verified SIMs in the scientific literature [60,61].
Protein stability analysis
I-Mutant version 2.0, an online support vector machine tool
based on the ProTherm database, was used to evaluate nsSNP-
induced changes in protein stability [62]. nsSNP protein-coding
sequences were submitted to I-Mutant 2.0 for 2 high-risk nsSNPs
that coincide with putative PTM sites, 5 low-risk nsSNPs that
coincide with putative PTM sites, and 12 additional high-risk
nsSNPs that do not coincide with predicted PTM sites. I-Mutant
2.0 estimates the free energy change value (DDG) by calculating
the unfolding Gibbs free energy value (DG) for the wild type
protein and subtracting it from that of the mutant protein (DDG
or DDG = DG mutant – DG wild type). It also predicts the sign
(increase or decrease) of the free energy change value (DDG),
along with a reliability index for the results (RI: 0–10, where 0 is
the lowest reliability and 10 is the highest reliability). A DDG ,0
corresponds to a decrease in protein stability, whereas a DDG .0
corresponds to an increase in protein stability. However, according
to the ternary classification system (SVM3), a large decrease in
protein stability corresponds to a DDG ,20.5 and a large
increase in protein stability corresponds to a DDG .0.5. In
contrast, DDG values that fall between 20.5 and 0.5 correspond
to relatively neutral protein stability [62,63]. The pH was set to 7
and the temperature was set to 25uC for all submissions.
Results and Discussion
SNP dataset
Polymorphism data for the TRIM22 gene were retrieved from
the NCBI dbSNP database, the Ensembl genome browser, and the
UniProt database [44–46]. According to these databases, the
TRIM22 gene contains 66 nsSNPs, 8 SNPs in its 59 UTR, and 32
SNPs in its 39 UTR. Of the 66 nsSNPs, 10 generate truncated
versions of the TRIM22 protein (nonsense and frameshift
mutations), whereas 56 introduce single amino acid changes
(missense mutations) into TRIM22 (Table S1). To determine
whether a given missense mutation affected TRIM22 function, we
subjected the latter 56 nsSNPs to a variety of in silico SNP
prediction algorithms. The results, which are summarized in
In Silico Analysis of Functional SNPs in the Human TRIM22 Gene
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Table 1, identified a number of nsSNPs with a high probability of
being deleterious to TRIM22 structure and/or function.
Non-synonymous SNP analysis
Our analyses included the following six in silico SNP prediction
algorithms: Polyphen-2, SIFT, nsSNP Analyzer, PhD-SNP,
PMUT, and SNPs&GO [47–52]. According to our Polyphen-2
results, 13 nsSNPs (23%) are damaging to TRIM22 function,
whereas 33 nsSNPs (59%) are benign. An additional 10 nsSNPs
(18%) are predicted to be ‘possibly damaging’ by Polyphen-2
(Table 1). Our SIFT analysis predicted that 19 nsSNPs (34%) are
deleterious to TRIM22 function and 37 nsSNPs (66%) are
tolerated. On the contrary, the nsSNP Analyzer predicted that 21
nsSNPs (38%) cause disease and 35 nsSNPs (62%) are neutral
(Table 1). Both PhD-SNP and PMUT predicted that 25 (45%)
nsSNPs are pathological and 31 (55%) nsSNPs are neutral
(Table 1). SNPs&GO analysis, which includes information from
the Gene Ontology annotation, predicted that 11 nsSNPs (20%)
cause disease and 45 nsSNPs (80%) are neutral (Table 1).
Interestingly, we found that the majority of potentially deleterious
nsSNPs were located in the B30.2 domain, including 3 nsSNPs
that were predicted to be damaging by all six SNP prediction
algorithms (P403T, T460I, and C494F). Because each algorithm
uses different parameters to evaluate the nsSNPs, nsSNPs with
more positive results are more likely to be truly deleterious. Here,
we classified nsSNPs as high-risk if they were predicted to be
deleterious by four or more SNP prediction algorithms. 14 nsSNPs
met this criteria and were selected for further analysis (Table 2, see
Table S2 for all 56 nsSNP prediction results).
Conservation profile of high-risk non-synonymous SNPs
Amino acids that are involved in important biological processes,
such as those located in enzymatic sites or required for protein-
protein interactions, tend to be more conserved than other
residues. As such, nsSNPs that are located at highly conserved
amino acid positions tend to be more deleterious than nsSNPs that
are located at non-conversed sites [3,64]. To further investigate
the potential effects of the 14 high-risk nsSNPs in Table 2, we
calculated the degree of evolutionary conservation at all amino
acid sites in the TRIM22 protein using the ConSurf web server.
ConSurf employs an empirical Bayesian method to determine
evolutionary conservation and identify putative structural and
functional residues [53]. For the purpose of this study, we focused
on amino acid sites that coincide in location with the 14 high-risk
nsSNPs; however, ConSurf also identified a number of other
residues that may be functionally relevant (Figures S1 and S2).
Table 1. Summary of prediction results for nsSNPs in the TRIM22 protein.
Prediction Number of nsSNPs (%)
PP-2 SIFT nsSNP AZ PhD-SNP PMUT SNPs&GO
Deleterious 13 (23) 19 (34) - - - -
PD 10 (18) - - - - -
Benign 33 (59) 37 (66) - - - -
Disease - - 21 (38) 25 (45) 25 (45) 11 (20)
Neutral - - 35 (62) 31 (55) 31 (55) 45 (80)
Percentage of total nsSNPs (56) shown in parentheses for each category; PD: possibly deleterious; PP-2: Polyphen-2; nsSNP AZ: nsSNP Analyzer.
doi:10.1371/journal.pone.0101436.t001
Table 2. TRIM22 nsSNPs predicted to be functionally significant by four or more SNP prediction algorithms.
nsSNP ID Mutation Domain # Del. Pred.
rs201847190 L68R Spacer 1 5
rs199625192 H73R Spacer 1 5
rs368058642 E135K Coiled-coil 4.5
rs374292901 I234N Spacer 2 5
rs61735273 S244L Spacer 2 5
rs371728648 G346S B30.2 5
rs191847788 K364N B30.2 4.5
rs375595000 P403T B30.2 6
rs370495523 L432W B30.2 4
rs187416296 R442C B30.2 5
rs377529439 F456I B30.2 5
rs371028900 T460I B30.2 6
rs200638791 P484S B30.2 4.5
rs200148337 C494F B30.2 6
# Del. Pred. = number of deleterious predictions.
doi:10.1371/journal.pone.0101436.t002
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ConSurf analysis revealed that residues L68, H73, E135, I234,
S244, G346, K364, P403, L432, R442, F456, T460, and C494 are
highly conserved (Conservation Score of 7–9). In addition,
ConSurf predicted that T460 was an important structural residue
(highly conserved and buried) and that L68, K364, and P403 were
important functional residues (highly conserved and exposed)
(Table 3). To identify putative structural and functional sites,
ConSurf combines evolutionary conservation data with solvent
accessibility predictions. Highly conserved residues are predicted
to be either structural or functional based on their location relative
to the protein surface or protein core [65]. Remarkably, two of the
three high-risk nsSNPs that were predicted to be deleterious by all
six SNP prediction algorithms (P403T and T460I) were also
identified as important structural or functional residues by
ConSurf (Table 2, 3). Taken together, our data strongly suggest
Table 3. Conservation profile of amino acids in TRIM22 that coincide in location with high-risk nsSNPs.
nsSNP ID Amino Acid CS ConSurf prediction
rs201847190 L68 8 Highly conserved and exposed (f)
rs199625192 H73 7 Exposed
rs368058642 E135 7 Exposed
rs374292901 I234 7 Buried
rs61735273 S244 8 Buried
rs371728648 G346 8 Buried
rs191847788 K364 9 Highly conserved and exposed (f)
rs375595000 P403 8 Highly conserved and exposed (f)
rs370495523 L432 8 Buried
rs187416296 R442 7 Exposed
rs377529439 F456 8 Buried
rs371028900 T460 9 Highly conserved and buried (s)
rs200638791 P484 6 Exposed
rs200148337 C494 8 Buried
CS: conservation score (1–4 = variable, 5 = average, 6–9 = conserved); (f): predicted functional site, (s): predicted structural site.
doi:10.1371/journal.pone.0101436.t003
Figure 1. Structural models for wild type TRIM22 and high-risk nsSNPs in the B30.2 domain. Putative structural models for the B30.2
domains of wild type TRIM22 and the 9 high-risk nsSNPs located in the B30.2 domain. Variable regions (v1-v4) are highlighted as follows: v1 blue, v2
orange, v3 magenta, and v4 green. Non-variable regions are shown in white and mutated amino acids are shown in yellow. Left image: Enlarged
reference image that illustrates the color and location of each variable region and the color of mutated amino acids (image shown is the v1-v4
regions of wild type TRIM22 and the P403 amino acid). Each of the 9 nsSNP images (small images on the right) show the putative 3D structure of wild
type TRIM22’s B30.2 domain on the left and the putative 3D structure of TRIM22’s B30.2 domain with the mutated amino acid (nsSNP) on the right.
The location of the amino acid in question is shown (yellow) on both wild type and nsSNP structures. All models were generated using the 3D-JigSaw
protein comparative modeling server and SPDBV (v4.1).
doi:10.1371/journal.pone.0101436.g001
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that the nsSNPs P403T and T460I are deleterious to TRIM22
structure and/or function.
Comparative modeling of high-risk non-synonymous
SNPs
To examine whether P403T and T460I altered the 3D structure
of TRIM22’s B30.2 domain, we individually substituted each
nsSNP into the wild type TRIM22 sequence and submitted the
sequences to 3D-Jigsaw for structural analysis. We also submitted
sequences for the remaining 7 high-risk nsSNPs in the B30.2
domain (i.e. G346S, K364N, L432W, R442C, F456I, P484S, and
C494F) since our in silico and ConSurf results indicated that these
nsSNPs were also highly likely to be deleterious. Theoretical
structural models were generated for each nsSNP using the 3D-
Jigsaw program, which constructs 3D models for proteins based on
homologues of known structure [54]. We then used Swiss-
PdbViewer to compare each nsSNP model to the predicted 3D-
Jigsaw model of wild type TRIM22 [55]. All of the nsSNPs altered
the putative 3D structure of wild type TRIM22’s B30.2 domain.
G346S, P40T, L432W, F456I, and C494F introduced an alpha
helix into the v2 region, whereas the other 4 nsSNPs introduced
beta strands into the v2 region (Figure 1). With the exception of
P484S, which introduced an alpha helix into the v3 region, all of
the nsSNP models contained elongated and/or additional beta
strands in the v3 region. Only G346S and F456I altered the v1
region (both introduced an alpha helix); however, all 9 nsSNPs
altered the length and/or number of beta strands in non-variable
regions of the B30.2 domain. Notably, P484S was the only nsSNP
model that contained fewer beta strands than wild type TRIM22
in certain regions (Figure 1). The majority of nsSNP models
contained a greater number of beta strands than wild type
TRIM22, resulting in overall net increase in beta strand
formation.
To extend our structural analysis, we used Tm-Align to
calculate the Tm-score and root mean square deviation (RMSD)
for each nsSNP model. Tm-score is used to assess topological
similarity between wild type and mutant models, whereas RMSD
is used to measure average distance between the a-carbon
backbones of wild type and mutant models [56,66]. A higher
RMSD typically indicates greater deviation between wild type and
mutant structures. The Tm-score and RMSD for each nsSNP
model is listed in Table 4. The maximum RMSD was 3.04
(R442C), followed by 3.03 (F456I), 3.00 (L432W), 2.96 (G346S),
and 2.80 (P484S). RMSD for nsSNPs K364N, P403T, T460I, and
C494F ranged from 1.58 to 1.99 A˚. These results indicate that 9
high-risk nsSNPs markedly alter the putative structure of
TRIM22’s B30.2 domain, in particular the surface-exposed v2
and v3 regions, and that they likely induce severe structural
changes in the TRIM22 protein.
Importantly, these nsSNPs may decrease flexibility in the v2 and
v3 regions of TRIM22. The v2/v3 regions of wild type TRIM22
are predicted to form relaxed loop segments, similar to the loops in
the recently solved 3D structure of rhesus monkey TRIM5a’s
B30.2 domain [26]. In contrast, the v2 and v3 regions of the
nsSNP models contain more rigid secondary structures, such as
alpha helices or beta strands (Figure 1). Since loop flexibility in
rhesus monkey TRIM5a is thought to facilitate restriction of
divergent retroviruses and to increase resistance to mutations in
the HIV-1 capsid protein, it is possible that these nsSNPs may
impair the antiviral activity and/or breadth of TRIM22. Further
experiments, such as the resolution of wild type TRIM22’s tertiary
structure, are required to address these possibilities.
Prediction of post-translational modification sites in
TRIM22
To investigate how nsSNPs may influence the post-translational
modification (PTM) of TRIM22, we used a variety of in silico
prediction tools to identify putative PTM sites in the TRIM22
protein. PTMs are involved in many biological processes,
including a number of canonical innate immune pathways, and
Table 4. RMSD (A˚) and TM-score for the 9 high-risk nsSNPs in
the B30.2 domain of TRIM22.
nsSNP ID Mutation RMSD (A˚) TM-Score
rs371728648 G346S 2.96 0.75184
rs191847788 K364N 1.72 0.93911
rs375595000 P403T 1.99 0.85389
rs370495523 L432W 3.00 0.70821
rs187416296 R442C 3.04 0.68305
rs377529439 F456I 3.03 0.73743
rs371028900 T460I 1.76 0.94873
rs200638791 P484S 2.80 0.75981
rs200148337 C494F 1.58 0.95645
RMSD and Tm-scores were calculated using Tm-Align.
doi:10.1371/journal.pone.0101436.t004
Table 5. Putative ubiquitylation and sumoylation sites in the
TRIM22 protein.
Ubiquitylation Sumoylation
UbPred BDM-PUB SUMOplot SUMOsp 2.0
93 (7e)* 6 (3e) 6 (3e) 85 (2e)
160 (7e)* 44 (1e) 153 (9e)* 153 (9e)*
173 (9e)* 85 (2e) 185 (4e)
204 (6e) 93 (7e)* 265 (6e)
257 (1e) 103 (6e)
430 (6e) 109 (9e)
160 (7e)*
173 (9e)*
265 (6e)
266 (9e)
268 (2e)
272 (6e)
273 (9e)
275 (7e)
324 (1e)
332 (2e)#
374 (1e)
380 (3e)
382 (1e)
Conservation score (CS) shown in parentheses (see Table 3 and Figure S1)
following amino acid site; Putative functional residues are indicated with bold
text, whereas putative structural residues are indicated with italicized text
(Figure S1); Residues predicted to undergo ubiquitylation or sumoylation by
both programs are indicated with an asterisk; Residues predicted to undergo
ubiquitylation or sumoylation that coincide with the location of nsSNPs are
indicated with a hashtag.
doi:10.1371/journal.pone.0101436.t005
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are essential for the regulation of protein structure and function
[57,67–69]. To analyze residues in TRIM22 that may undergo
ubiquitylation or sumoylation, we used the UbPred, BDM-PUB,
SUMO-plot, and SUMOsp 2.0 programs. The GPS 2.1 and
NetPhos 2.0 servers were used to predict serine, threonine, and
tyrosine phosphorylation sites in the TRIM22 protein
[2,58,59,70].
UbPred predicted that 6 lysine residues in TRIM22 undergo
ubiquitylation. In contrast, BDM-PUB predicted that 19 lysine
residues undergo ubiquitylation. Both UbPred and BDM-PUB
predicted that residues K63, K160, and K173 undergo ubiquityla-
tion (Table 5). According to ConSurf, these 3 lysine residues are
highly conserved and exposed to the protein surface. ConSurf also
predicted that K173 was a functional residue (Figure S1).
SUMOplot predicted that 4 lysine residues in TRIM22 undergo
sumoylation, whereas SUMOsp 2.0 predicted that 2 lysine
residues undergo sumoylation. Both programs predicted that
K153 undergoes sumoylation (Table 5). Similar to K173, ConSurf
showed that K153 is highly conserved and exposed to the protein
surface. ConSurf also predicted that K153 was a functional residue
(Figure S1).
In addition to putative sumoylation sites, we also identified 7
potential sumo-interacting motifs (SIM) (Figure 2A). SIMs are
short hydrophobic motifs that interact non-covalently with other
sumoylated proteins. The best characterized SIMs have the
consensus sequence V/I/L-x-V/I/L-V/I/L or V/I/L-V/I/L-x-
V/I/L [61]. Notably, 5 of the putative SIMs are highly conserved
in multiple TRIM22 orthologues and 3 are also present in the
human and rhesus monkey TRIM5a proteins (Figure 2B). In
addition, 2 TRIM5a SIMs (ILGV and VIGL) were previously
shown to be required for TRIM5a-mediated antiviral activity.
SIM mutations in the rhesus monkey TRIM5a protein abolished
HIV-1 restriction and disrupted TRIM5a trafficking to SUMO-1
nuclear bodies. Moreover, SIM mutations in the human TRIM5a
protein abrogated N-MLV restriction by preventing TRIM5a
binding to the sumoylated N-MLV capsid protein [60,71]. More
studies are needed to determine the role that SIMs play in
TRIM22-mediated antiviral activity.
To identify putative phosphorylation sites in TRIM22, we used
GPS 2.1 and NetPhos 2.0 servers. The GPS 2.1 server predicted
that there were 31 serine-specific phosphorylation sites, 13
threonine-specific sites, and 11 tyrosine-specific sites in the
TRIM22 protein. Conversely, NetPhos 2.0 predicted that there
were 19 serine-specific phosphorylation sites, 4 threonine-specific
sites, and 2 tyrosine-specific sites (Table 6). 16 serine residues, 3
threonine residues, and 2 tyrosine residues were predicted to be
phosphorylated by both GPS 2.1 and NetPhos 2.0 servers. Many
of these putative phosphorylation sites are highly conserved among
multiple TRIM22 orthologues and several were predicted to be
important structural or functional residues by ConSurf (Table 6,
Figure S1). Although TRIM22 phosphorylation has never been
demonstrated experimentally, our results suggest that it may
Figure 2. Putative sumo-interacting motifs (SIMs) in TRIM22. A. List of putative SIMs in the TRIM22 protein, including the sequence and
domain location for each SIM (amino acids are indicated in parentheses); Red and blue amino acids are predicted functional and structural residues,
respectively (ConSurf analysis Figure S1); Asterisk: SIMs that are conserved in all mammalian TRIM22 orthologues except elephant; Double asterisk:
SIMs that are not found in TRIM5a, but are replaced by a different SIM (e.g. VLTL, IVPL). B. Alignment of mammalian TRIM22, human TRIM5a, and
rhesus monkey TRIM5a amino acid sequences (amino acids 350–444 of the B30.2 domain are shown). Conserved SIMs are highlighted in magenta
and other SIMs are highlighted in light blue. Conserved amino acids are indicated with an asterisk.
doi:10.1371/journal.pone.0101436.g002
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undergo phosphorylation at a number of sites. Of interest, other
TRIM proteins have been shown to undergo phosphorylation,
including the antiviral TRIM19 and TRIM21 proteins [72–76].
Several putative PTMs coincide in location with nsSNPs in the
TRIM22 gene (T61, T232, S244, T294, T330, K332, and T460).
S244 and T460 are particularly interesting because both sites are
highly conserved among TRIM22 orthologues and S244L and
T460I were predicted to be deleterious by 5 and 6 in silico
algorithms, respectively (Table 2, 3). In addition, T460 was
predicted to be a critical structural residue by ConSurf. Although
the consequences of TRIM22 phosphorylation are currently
unknown, the mutation of phosphorylation sites in other proteins
has been shown to profoundly alter protein function by, for
example, altering protein stability, localization, or protein-protein
interactions. To this end, we used I-Mutant to predict whether
S244L and T460I altered the stability of the TRIM22 protein. I-
Mutant is a support vector machine-based tool that predicts
changes in protein stability following single site mutations by
estimating free energy changes as well as the direction of the
change (increase or decrease) [62]. Both S244L and T460I were
predicted to be less stable than the wild type protein, with free
energy change values of 20.83 and 21.38, respectively (Table 7).
The I-Mutant results for the 12 high-risk nsSNPs that do not
coincide with putative PTM sites, plus the results for the 5 low-risk
nsSNPs that do coincide with putative PTM sites, are also shown
in Table 7.
It is possible that the phosphorylation of TRIM22 at sites S244
and/or T460 is required for some integral TRIM22 function and
that the nsSNPs S244L and T460I impair this function; however,
these nsSNPs may also impair protein stability, which would likely
amplify any detrimental of PTM impairment. Many additional
high-risk nsSNPs, plus several low-risk nsSNPs located at putative
Table 6. Putative phosphorylation sites in the TRIM22 protein.
GPS 2.1 NetPhos 2.0
Serine Threonine Tyrosine Serine Threonine Tyrosine
4 (1e) 23 (7e) 175 (1b) 46 (7e)* 130 (7b) 356 (8b)*
27 (9e) 61 (1b)# 298 (1e) 50 (1e) 263 (3e)* 479 (5b)*
46 (7e)* 170 (1e) 299 (6b) 54 (3e)* 325 (1e)*
54 (3e)* 220 (1e) 355 (5b) 87 (4e)* 330 (1e)*#
87 (4e)* 232 (1e)# 356 (8b)* 244 (8b)*#
122 (9e) 263 (3e)* 394 (1b) 245 (8b)*
231 (4e) 294 (7e)# 398 (7b) 259 (9e)*
235 (9e) 311 (2b) 418 (8b) 261 (2e)*
244 (8b)*# 325 (1e)* 467 (8b) 269 (1e)*
245 (8b)* 330 (1e)*# 479 (5b)* 271 (8e)*
259 (9e)* 433 (7b) 481 (8e)* 276 (5e)*
261 (2e)* 460 (9b)# 284 (5e)*
269 (1e)* 492 (6e) 373 (8b)*
271 (8e)* 383 (3e)*
276 (5e)* 384 (9e)*
284 (5e)* 399 (7b)
309 (8e) 425 (6e)*
312 (6e) 426 (4e)*
317 (9b) 475 (8e)
373 (8b)*
376 (2e)*
377 (1e)
383 (3e)*
384 (9e)*
391 (3e)
424 (7e)
425 (6e)*
426 (4e)*
455 (9b)
497 (9e)
498 (7e)
Conservation score (CS) shown in parentheses (see Table 3 and Figure S1) following amino acid site; Putative functional residues are indicated with bold text, whereas
putative structural residues are indicated with italicized text (Figure S1); Residues predicted to undergo phosphorylation by both GPS 2.1 and NetPhos 2.0 are indicated
with an asterisk; Residues predicted to undergo phosphorylation that also coincide with the location of nsSNPs are indicated with a hashtag.
doi:10.1371/journal.pone.0101436.t006
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Table 7. I-Mutant results for selected nsSNPs in the TRIM22 protein.
nsSNP ID Mutation # Del. Pred. DDG Sign of DDG PTM ConSurf
rs192306924 T61N 1 0.56 Decrease (1) Yes 1b
rs201847190 L68R 5 21.02 Decrease (7)* No 8e
rs199625192 H73R 5 0.23 Decrease (3) No 7e
rs368058642 E135K 4.5 21.00 Decrease (9)* No 7e (9b)
rs2291843 T232A 0 20.53 Decrease (5) Yes 1e
rs374292901 I234N 5 20.80 Decrease (1) No 7b (9e)
rs61735273 S244L 5 20.83 Decrease (2) Yes 8b
rs73404240 T294K 2 20.63 Decrease (5) Yes 7e
rs201494620 T330I 1 22.14 Decrease (7)* Yes 1e
rs368220166 K332N 1 20.42 Decrease (2) Yes 2e
rs371728648 G346S 5 20.27 Decrease (7) No 8b
rs191847788 K364N 4.5 21.09 Decrease (4) No 9e
rs375595000 P403T 6 22.64 Decrease (8) No 8e
rs370495523 L432W 4 0.08 Decrease (6) No 8b
rs187416296 R442C 5 21.23 Decrease (6)* No 7e
rs377529439 F456I 5 21.59 Decrease (8)* No 8b (9b)
rs371028900 T460I 6 21.38 Decrease (5)* Yes 9b
rs200638791 P484S 4.5 22.97 Decrease (9)* No 6e (9b)
rs200148337 C494F 6 20.21 Decrease (4) No 8b
# Del. Pred. = number of deleterious predictions; nsSNPs with 4 or more deleterious predictions are considered high-risk nsSNPs, while nsSNPs with less than 4
deleterious predictions are considered low-risk; DDG: free energy change value in Kcal/mol (.0 increase, ,0 decrease, .0.5 large increase, ,20.5 large decrease); Sign
of DDG: the direction of the change (increase or decrease); The reliability index (RI) from 0–9 is shown in parentheses, where 0 is the lowest RI and 9 is the highest); PTM:
predicted post-translational modification site; ConSurf results are shown in the last column (number represents the conservation score (CS) from 1–9, letter represents
whether the residue was predicted to be exposed (e) or buried (b), putative functional residues are indicated with bold text; whereas putative structural residues are
indicated with italicized text (Figure S1); Sites with an additional ConSurf result in parentheses are located next to putative functional (9e) or structural (9b) residues;
nsSNPs with the largest predicted stability decreases (DDG ,21.0) that also have a RI score of $5 are indicated with an asterisk.
doi:10.1371/journal.pone.0101436.t007
Figure 3. Putative functional sites in the TRIM22 protein. Schematic depicting the approximate location of the top predicted PTM sites
(ubiquitylation, sumoylation, and phosphorylation), the 14 high-risk nsSNPs in TRIM22, the 3 sumo-interacting motifs (SIMs), and the 2 high-risk
nsSNP sites (S244L and T460I) predicted to undergo phosphorylation in the wild type TRIM22 protein. Several sites of known functional importance
are marked on the TRIM22 protein (top image), including the C15/C18 residues (required for TRIM22 E3 ligase activity), the C97/H100 residues (part of
the zinc-binding motif in BB2), and the nuclear localization signal (NLS) [81–83]. The ‘antiviral patch’ region, which was previously shown to be
integral for the antiviral activity of TRIM5a, is shown in the B30.2 domain, as well as the approximate location of each variable region (v1-v4, bright
blue areas) [28,33]. Amino acids 491–494 were previously shown to be required for the nuclear localization of TRIM22 [84]. RING, B-box 2 (BB2), coiled-
coil (CC), and B30.2 (PRY/SPRY) domains are listed.
doi:10.1371/journal.pone.0101436.g003
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PTM sites, also decreased TRIM22 protein stability (Table 7). A
number of studies have shown that decreased protein stability
leads to increased protein misfolding, aggregation, and degrada-
tion. Accordingly, decreased stability typically results in decreased
net function [77–80]. Future in-depth studies are required to
investigate the effects of these nsSNPs on the structure and
function of TRIM22’s B30.2 domain. Pertinent TRIM22 sites that
are predicted to be highly deleterious and/or undergo PTMs are
depicted in Figure 3.
Conclusions
Our results demonstrate that multiple nsSNPs in the antiviral
TRIM22 gene may be deleterious to TRIM22 structure and/or
function. Most of these high-risk nsSNPs are located at highly
conserved amino acid sites in a protein-protein interaction module
called the B30.2 domain. In this study, we show that 9 of the top
high-risk nsSNPs disrupt the putative structure of TRIM22’s
B30.2 domain, particularly the surface-exposed v2 and v3 regions.
In the closely-related TRIM5a protein, these same regions were
previously shown to play a key role in retroviral restriction. In
addition to these findings, we also identify several TRIM22 sites
that may undergo post-translational modification, including sites
that coincide with the location of high-risk nsSNPs. This study is
the first systematic and extensive in silico analysis of functional
SNPs in the TRIM22 gene.
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